1. Zarrinpar A, Busuttil RW. Liver transplantation: past, present and future. Nat Rev Gastroenterol Hepatol 2013;10:434-40.
2. Bodzin AS, Baker TB. Liver Transplantation Today: Where We Are Now and Where We Are Going. Liver Transpl 2018;24:1470-5.
3. Goldaracena N, Barbas AS. Living donor liver transplantation. Curr Opin Organ Transplant 2019;24:131-7.
4. Hackl C, Schmidt KM, Susal C, et al. Split liver transplantation: Current developments. World J Gastroenterol 2018;24:5312-21.
5. Vodkin I, Kuo A. Extended Criteria Donors in Liver Transplantation. Clin Liver Dis 2017;21:289-301.
6. Polaris Observatory C. Global prevalence, treatment, and prevention of hepatitis B virus infection in 2016: a modelling study. Lancet Gastroenterol Hepatol 2018;3:383-403.
7. Liang X, Bi S, Yang W, et al. Epidemiological serosurvey of hepatitis B in China--declining HBV prevalence due to hepatitis B vaccination. Vaccine 2009;27:6550-7.
8. Angelico M, Nardi A, Marianelli T, et al. Hepatitis B-core antibody positive donors in liver transplantation and their impact on graft survival: evidence from the Liver Match cohort study. J Hepatol 2013;58:715-23.
9. Wong TC, Fung JY, Cui TY, et al. Liver transplantation using hepatitis B core positive grafts with antiviral monotherapy prophylaxis. J Hepatol 2019;70:1114-22.
10. Cholongitas E, Papatheodoridis GV, Burroughs AK. Liver grafts from anti-hepatitis B core positive donors: a systematic review. J Hepatol 2010;52:272-9.
11. Udayakumar VP, Surendran S, Padma UD. Utilization of hepatitis B core antibody positive grafts in living donor liver transplantation. Indian J Gastroenterol 2018;37:39-43.
12. Skalski M, Patkowski W, Grat M, et al. Utilization of Donors with Hepatitis B Core Antibodies in Liver Transplantation. Ann Transplant 2015;20:667-75.
13. Kim HY, Choi JY, Park CH, et al. Adult Living Donor Liver Transplantation Using Hepatitis B Core Antibody-Positive Grafts in Korea, a Hepatitis B-endemic Region. Gut Liver 2011;5:363-6.
14. Soejima Y, Shimada M, Taketomi A, et al. Successful living donor liver transplantation using a graft from a hepatitis B surface antigen-positive donor. Liver Int 2007;27:1282-6.
15. Loggi E, Micco L, Ercolani G, et al. Liver transplantation from hepatitis B surface antigen positive donors: a safe way to expand the donor pool. J Hepatol 2012;56:579-85.
16. Hwang S, Lee SG, Park KM, et al. Five-year follow-up of a hepatitis B virus-positive recipient of hepatitis B surface antigen-positive living donor liver graft. Liver Transpl 2006;12:993-7.
17. Saidi RF, Jabbour N, Shah SA, et al. Liver transplantation from hepatitis B surface antigen-positive donors. Transplant Proc 2013;45:279-80.
18. Ju W, Chen M, Guo Z, et al. Allografts positive for hepatitis B surface antigen in liver transplant for disease related to hepatitis B virus. Exp Clin Transplant 2013;11:245-9.
19. Ballarin R, Cucchetti A, Russo FP, et al. Long term follow-up and outcome of liver transplantation from hepatitis B surface antigen positive donors. World J Gastroenterol 2017;23:2095-105.
20. Jeng LB, Thorat A, Yang HR, et al. Successful use of hepatitis B surface antigen-positive liver grafts - an effective source for donor organs in endemic areas: a single-center experience. Ann Transplant 2015;20:103-11.
21. Krishnamoorthi R, Manickam P, Cappell MS. Liver transplantation of hepatitis B surface antigen positive donors to hepatitis B core antibody recipients: analysis of 27 patients. Minerva Gastroenterol Dietol 2014;60:113-8.
22. Li Z, Hu Z, Xiang J, et al. Use of hepatitis B surface antigen-positive grafts in liver transplantation: a matched analysis of the US National database. Liver Transpl 2014;20:35-45.
23. Wei L, Chen D, Zhang B, et al. Long-term outcome and recurrence of hepatitis B virus following liver transplantation from hepatitis B surface antigen-positive donors in a Chinese population. J Viral Hepat 2018;25:1576-81.
24. Yu S, Yu J, Zhang W, et al. Safe use of liver grafts from hepatitis B surface antigen positive donors in liver transplantation. J Hepatol 2014;61:809-15.
25. Kurth T, Walker AM, Glynn RJ, et al. Results of multivariable logistic regression, propensity matching, propensity adjustment, and propensity-based weighting under conditions of nonuniform effect. Am J Epidemiol 2006;163:262-70.
26. Caviglia GP, Abate ML, Tandoi F, et al. Quantitation of HBV cccDNA in anti-HBc-positive liver donors by droplet digital PCR: A new tool to detect occult infection. J Hepatol 2018;69:301-7.
27. Ravaioli M, Grande G, Di Gioia P, et al. Risk Avoidance and Liver Transplantation: A Single-center Experience in a National Network. Ann Surg 2016;264:778-86.
28. Brancaccio G, Gaeta GB. Prophylaxis of Hepatitis B Virus (HBV) Re-Infection in Liver Transplantation: Is the Reappearance of Hepatitis B Surface Antigen (HBsAg) Significant? Ann Transplant 2020;25:e920969.
29. Huprikar S, Danziger-Isakov L, Ahn J, et al. Solid organ transplantation from hepatitis B virus-positive donors: consensus guidelines for recipient management. Am J Transplant 2015;15:1162-72.
30. Chinese Society of Organ Transplantation CMA, Chinese Society of Hepatology CMA. [The practice guideline on prophylaxis and treatment of hepatitis B for liver transplantation in China (2016 edition)]. Zhonghua Gan Zang Bing Za Zhi 2016;24:885-91.
31. Villanueva A. Hepatocellular Carcinoma. N Engl J Med 2019;380:1450-62.
32. Levrero M, Zucman-Rossi J. Mechanisms of HBV-induced hepatocellular carcinoma. J Hepatol 2016;64:S84-S101.
33. Yip TC, Wong VW, Chan HL, et al. Tenofovir Is Associated With Lower Risk of Hepatocellular Carcinoma Than Entecavir in Patients With Chronic HBV Infection in China. Gastroenterology 2020;158:215-25 e6.